| Year |
Citation |
Score |
| 2023 |
Mallet C, Desmeules J, Pegahi R, Eschalier A. An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact. Journal of Pain Research. 16: 1081-1094. PMID 37016715 DOI: 10.2147/JPR.S393809 |
0.39 |
|
| 2021 |
Lamoine S, Cumenal M, Barriere DA, Pereira V, Fereyrolles M, Prival L, Barbier J, Boudieu L, Brasset E, Bertin B, Renaud Y, Miot-Noirault E, Civiale MA, Balayssac D, Aissouni Y, ... Eschalier A, et al. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice. International Journal of Molecular Sciences. 23. PMID 35008525 DOI: 10.3390/ijms23010098 |
0.667 |
|
| 2020 |
Å Nilsson JL, Mallet C, Shionoya K, Blomgren A, Sundin AP, Grundemar L, Boudieu L, Blomqvist A, Eschalier A, Nilsson UJ, Zygmunt PM. Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity. European Journal of Medicinal Chemistry. 113042. PMID 33257173 DOI: 10.1016/j.ejmech.2020.113042 |
0.425 |
|
| 2019 |
Barrière DA, Boumezbeur F, Dalman R, Cadeddu R, Richard D, Pinguet J, Daulhac L, Sarret P, Whittingstall K, Keller M, Mériaux S, Eschalier A, Mallet C. Acetaminophen, a centrally-acting analgesic involving the periaqueductal grey. British Journal of Pharmacology. PMID 31734950 DOI: 10.1111/Bph.14934 |
0.662 |
|
| 2018 |
Poupon L, Lamoine S, Pereira V, Barriere DA, Lolignier S, Giraudet F, Aissouni Y, Meleine M, Prival L, Richard D, Kerckhove N, Authier N, Balayssac D, Eschalier A, Lazdunski M, et al. Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin. Neuropharmacology. 140: 43-61. PMID 30056126 DOI: 10.1016/J.Neuropharm.2018.07.026 |
0.669 |
|
| 2017 |
Chenaf C, Chapuy E, Libert F, Marchand F, Courteix C, Bertrand M, Gabriel C, Mocaër E, Eschalier A, Authier N. Agomelatine: a new opportunity to reduce neuropathic pain-preclinical evidence. Pain. 158: 149-160. PMID 27984527 DOI: 10.1097/j.pain.0000000000000738 |
0.308 |
|
| 2014 |
Dalmann R, Daulhac L, Antri M, Eschalier A, Mallet C. Supra-spinal FAAH is required for the analgesic action of paracetamol in an inflammatory context. Neuropharmacology. 91: 63-70. PMID 25448494 DOI: 10.1016/j.neuropharm.2014.11.006 |
0.385 |
|
| 2014 |
Rodrigues N, Bennis K, Vivier D, Pereira V, Chatelain FC, Chapuy E, Deokar H, Busserolles J, Lesage F, Eschalier A, Ducki S. Synthesis and structure-activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel European Journal of Medicinal Chemistry. 75: 391-402. PMID 24561669 DOI: 10.1016/J.Ejmech.2014.01.049 |
0.325 |
|
| 2013 |
Barrière DA, Mallet C, Blomgren A, Simonsen C, Daulhac L, Libert F, Chapuy E, Etienne M, Högestätt ED, Zygmunt PM, Eschalier A. Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain. Plos One. 8: e70690. PMID 23940628 DOI: 10.1371/journal.pone.0070690 |
0.722 |
|
| 2012 |
Mallet C, Barrière DA, Eschalier A. [Paracetamol: a promising ancestor]. Therapie. 67: 277-81. PMID 23110826 DOI: 10.2515/therapie/2012039 |
0.664 |
|
| 2010 |
Mallet C, Barrière DA, Ermund A, Jönsson BA, Eschalier A, Zygmunt PM, Högestätt ED. TRPV1 in brain is involved in acetaminophen-induced antinociception. Plos One. 5. PMID 20862299 DOI: 10.1371/journal.pone.0012748 |
0.714 |
|
| 2008 |
Mallet C, Daulhac L, Bonnefont J, Ledent C, Etienne M, Chapuy E, Libert F, Eschalier A. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain. 139: 190-200. PMID 18485596 DOI: 10.1016/j.pain.2008.03.030 |
0.346 |
|
| 2006 |
Pickering G, Loriot MA, Libert F, Eschalier A, Beaune P, Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clinical Pharmacology and Therapeutics. 79: 371-8. PMID 16580905 DOI: 10.1016/j.clpt.2005.12.307 |
0.307 |
|
| 2004 |
Bonnefont J, Courade JP, Alloui A, Eschalier A. [Antinociceptive mechanism of action of paracetamol]. Drugs. 1-4. PMID 14758785 |
0.319 |
|
| 2003 |
Marchand F, Alloui A, Pelissier T, Hernández A, Authier N, Alvarez P, Eschalier A, Ardid D. Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat. Brain Research. 980: 117-20. PMID 12865165 DOI: 10.1016/S0006-8993(03)02946-9 |
0.311 |
|
| 2003 |
Marchand F, Alloui A, Chapuy E, Jourdan D, Pelissier T, Ardid D, Hernandez A, Eschalier A. Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats. Pain. 103: 229-35. PMID 12791429 DOI: 10.1016/S0304-3959(03)00168-4 |
0.312 |
|
| 2003 |
Alloui A, Chassaing C, Schmidt J, Ardid D, Dubray C, Cloarec A, Eschalier A. Paracetamol exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats. European Journal of Pharmacology. 443: 71-7. PMID 12044794 DOI: 10.1016/s0014-2999(02)01578-9 |
0.303 |
|
| Show low-probability matches. |